1. American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma 
Sergio Giralt, Laurent Garderet, Brian Durie, Gordon Cook, Gosta Gahrton, Benedetto Bruno, Paremesweran Hari, Henk Lokhorst, Phillip McCarthy, Amrita Krishnan, Pieter Sonneveld, Harmut Goldschmidt, Sundar Jagannath, Bart Barlogie, Maria Mateos, Peter Gimsing, Orhan Sezer, Joseph Mikhael, Jin Lu, Meletios Dimopoulos, Amitabha Mazumder, Antonio Palumbo, Rafat Abonour, Kenneth Anderson, Michel Attal, Joan Blade, Jenny Bird, Michele Cavo, Raymond Comenzo, Javier de la Rubia, Hermann Einsele, Ramon Garcia-Sanz, Jens Hillengass, Sarah Holstein, Hans Erik Johnsen, Douglas Joshua, Guenther Koehne, Shaji Kumar, Robert Kyle, Xavier Leleu, Sagar Lonial, Heinz Ludwig, Hareth Nahi, Anil Nooka, Robert Orlowski, Vincent Rajkumar, Anthony Reiman, Paul Richardson, Eloisa Riva, Jesus San Miguel, Ingemar Turreson, Saad Usmani, David Vesole, William Bensinger, Muzaffer Qazilbash, Yvonne Efebera, Mohamed Mohty, Christina Gasparreto, James Gajewski, Charles F. LeMaistre, Chris Bredeson, Phillipe Moreau, Marcelo Pasquini, Nicolaus Kroeger, Edward Stadtmauer 
Biology of Blood and Marrow Transplantation 
Volume 21, Issue 12, Pages (December 2015)
DOI: /j.bbmt
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
(A) Number or salvage HCT performed for MM in North America over time (CIBMTR registry). (B) Type of salvage HCT performed for MM over time (CIBMTR registry).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
(A) Since 1995, evolution of salvage treatment after autologous transplantation in Europe: no transplantation versus autologous transplantation data is incomplete (EBMT registry). (B) Since 1995, evolution of salvage autologous transplantation in Europe: single (AUTO1) versus double (AUTO2) versus tandem auto-allo (ALLO2) data is incomplete (EBMT registry).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
(A) Expert consensus on role of autologous HCT as consolidation therapy of an initial remission after first autograft of greater than 24 months (0 strongly agree and 10 strongly disagree, ordinate axis is the number of people who voted). (B) Expert consensus on role of autologous HCT as consolidation therapy of an initial remission after first autograft of less than 6 months (0 strongly agree and 10 strongly disagree, ordinate axis is the number of people who voted). (C) Expert consensus on role of autologous HCT as consolidation therapy of an initial remission after first autograft of between 12 and 24 months (0 strongly agree and 10 strongly disagree, ordinate axis is the number of people who voted).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

5. Figure 4
(A) Expert consensus on role of allogeneic HCT as consolidation therapy of an initial remission after first autograft of greater than 24 months (0 strongly agree and 10 strongly disagree, ordinate axis is the number of people who voted). (B). Expert consensus on role of allogeneic HCT as consolidation therapy of an initial remission after first autograft between 12 and 24 months (0 strongly agree and 10 strongly disagree, ordinate axis is the number of people who voted). (C) Expert consensus on role of allogeneic HCT as consolidation therapy of an initial remission after first autograft of less than 6 months (0 strongly agree and 10 strongly disagree, ordinate axis is the number of people who voted).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions